The Cooper Companies, Inc. (COO)

The Cooper Companies, Inc. (COO) is a healthcare company (medical instruments & supplies) based in the United States. The share price is $61.31, down 0.92% on the day, which values the company at $11.66B. Price as of 17 Nov 2026, 17:16 UTC, from Yahoo Finance.

Key facts

Share price
$61.31−0.92% today
Market value
$11.66B
P/E ratio
21.1×last 12 months
Forward P/E
13.1×
Funk Score
61/100
Against its own history
Well below its usual priceusual price $89.04
200-week average
$83.7427% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

The Cooper Companies, Inc. in more detail

COO trades at 21.1× its last twelve months' earnings, 13.1× next year's expected earnings, 2.8× sales. Measured against its own history, the price is 31% below what its usual multiples would imply ($89.04) — well below its usual price. It sits 27% below its 200-week average of $83.74.

Over the last five fiscal years The Cooper Companies, Inc. has compounded revenue 11.0% a year, earnings per share 9.2% a year, free cash flow 19.7% a year. Its Funk Score is 61 out of 100 (financial strength 4.7, profitability 5.2, growth 6.9, value 7.6, each out of 10).

In its favour: Altman Z in the safe zone; Five straight years of revenue growth. Worth checking: Low return on invested capital.

7 of the superinvestors tracked here hold COO, including Barry Rosenstein (13.7% of the portfolio), Glenn Greenberg (4.9% of the portfolio), Mark Boyar (1.2% of the portfolio).

Superinvestors holding COO

7 of the investors tracked here report a position in their latest 13F filing.

Compare

Health Care companies of similar size

Side by side:COO vs ALGN (The Cooper Companies, Inc. vs Align Technology)COO vs RDY (The Cooper Companies, Inc. vs Dr. Reddy's Laboratories)COO vs PEN (The Cooper Companies, Inc. vs Penumbra)COO vs FMS (The Cooper Companies, Inc. vs Fresenius Medical Care)COO vs SNN (The Cooper Companies, Inc. vs Smith & Nephew)

All health care companies by market valueLargest companies in the United StatesAll stocks A–Z

The Cooper Companies, Inc. (COO): questions and answers

What is COO's P/E ratio?

The Cooper Companies, Inc. trades at 21.1× its last twelve months' earnings and 13.1× next year's expected earnings. At its fiscal year-ends over the past 18 years the P/E ranged from 7.0× to 91.9×, with a median of 31.3×.

What is COO's PEG ratio?

The Cooper Companies, Inc.'s PEG ratio is 0.59 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

What is The Cooper Companies, Inc.'s market cap?

The Cooper Companies, Inc. is valued at $11.66B at a share price of $61.31.

Is COO overvalued or undervalued?

Against its own history, COO is well below its usual price: the price is 31% below the $89.04 implied by the median multiples it has traded at (price / earnings, price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is COO above its 200-week moving average?

No. COO is 26.8% below its 200-week average of $83.74. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is The Cooper Companies, Inc. growing?

Over the last five fiscal years The Cooper Companies, Inc.'s revenue grew 11.0% a year and its earnings per share 9.2% a year; over ten years revenue grew 8.6% a year.

Cite this page

Funkfolio, “The Cooper Companies, Inc. (COO) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/COO

Underlying data: Yahoo Finance; company filings with the SEC.